Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
159 results about "Homeostatic mechanism" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Homeostasis is brought about by a natural resistance to change in the optimal conditions, and equilibrium is maintained by many regulatory mechanisms. All homeostatic control mechanisms have at least three interdependent components for the variable being regulated: a receptor, a control centre, and an effector.
Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes
InactiveUS7223728B2Lower blood sugar levelsIncrease secretionPeptide/protein ingredientsMetabolism disorderInsulin dependent diabetesSide effect
Thiazolidinedione (TZD) and its pharmacologically active derivatives can be used, in combination with agonists of glucagon-like peptide-1 (GLP-1), to treat non-insulin dependent diabetes mellitus, optionally with other therapies, by improving glycemic control while minimizing side effects, such as heart hypertrophy and elevated fed-state plasma glucose, which are associate with both TZD and GLP-1 monotherapies. Thus, the co-administration of TZD and GLP-1 helps regulate glucose homeostasis in Type II diabetic patients.
Owner:ELI LILLY & CO
Gallium complexes of 3-hydroxy-4-pyrones to treat cancer
Disclosed are pharmaceutical compositions that comprise gallium complexes of 3-hydroxy-4-pyrones. These compositions provide enhanced gallium bioavailability particularly when orally administered as compared to the gallium bioavailability achieved by use of pharmaceutical compositions containing gallium salts. Compositions included in this invention are useful in providing gallium to humans and other mammals for a wide variety of medical and veterinary applications, including the treatment, prevention, or diagnosis of hypercalcemia, certain cancers, certain disorders of calcium homeostasis, and certain bone diseases including osteoporosis, osteopenia, and Paget's disease.
Owner:BERNSTEIN LAWRENCE RICHARD
Method and system of breathing therapy for reducing sympathetic predominance with consequent positive modification of hypertension
InactiveUS20060047202A1Avoid influenceReduction in “ tenseness ”Gymnastic exercisingCatheterDiseaseNervous system
The invention specifies a method and system for leading a person suffering from “sympathetic predominance”, a specific symptom of which is “hypertension”, to breathe according to a certain pattern for the express purpose of positively altering the condition of sympathetic predominance (over activation), having the effect of bringing the autonomic nervous system into the state of balance, with consequent reductions in “tenseness”, blood pressure, muscular tightness, and emotional strain, as well as the alleviation of the myriad of subtle neuro-physiological consequences resulting from sympathetic predominance potentially including headaches, anxiety, sleep disorders, allergies, and other maladies that have yet to be attributed to this condition, thus leading to a general improvement in health, well being, and homeostasis. It accomplishes this by systematically reducing the breathing frequency with consequent increases in breathing depth, the ultimate goal being the realization and ongoing maintenance of 1 complete breathing cycle in 11.76 seconds or 5 complete breathing cycles in 58.8 seconds, the result being improved health, well being, and homeostasis.
Owner:ELLIOTT STEPHEN BENNETT
Use of WNT inhibitors to augment therapeutic index of chemotherapy
InactiveUS20080075714A1Increase dosePeptide/protein ingredientsAntibody mimetics/scaffoldsIntestinal structureWnt inhibitor
Methods and compositions are provided for the protection of normal cells from cytoreductive therapy that target proliferating cells, by administering an inhibitor of Wnt signaling pathways. Wnt signaling is critically important for homeostasis of the epithelial lining of the adult intestine and other proliferating normal adult tissues.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
InactiveUS20050222270A1Stable and lasting improved neural homeostasisBiocideOrganic active ingredientsDiseaseNervous system
An NMDA antagonist (such as ketamine) is administered with a safener (such as clonidine) in patients suffering from neurologic disorders other than pain. The ketamine is adminsitered at a dosage that causes slurred speech, for a span of several days. This treatment enables a patient's nervous system to return to a healthy “set point”, also called an improved stable neural homeostasis, in a manner similar to a broken bone healing itself if protected from jostling and reinjury by a cast. In at least some patients, this treatment can ease problems such as addictions to illegal or pain-killing drugs, nicotine, or alcohol, compulsive or criminal behavioral problems, severe depression, obsessive-compulsive disorders, phobias, etc. It may also provide some relief in some patients for problems such as chronic fatigue, chemical sensitivities, allergies, autoimmune disorders, and diabetes.
Owner:OLNEY JOHN W +3
Solid pharmaceutical compositions for the oral administration of gallium
The subjects of this invention are pharmaceutical compositions that comprise gallium complexes of 3-hydroxy-4-pyrones. The compositions have been developed to provide pharmaceutically acceptable gallium bioavailability together with low toxicity, particularly for oral administration. Compositions included in this invention should be useful in providing gallium to humans and other animals for a wide variety of medical and veterinary applications, including the treatment, prevention, or diagnosis of certain bone diseases, certain cancers, and certain disorders of calcium homeostasis.
Owner:BERNSTEIN LAWRENCE RICHARD
Thermotherapy System Based on Redox Potential
InactiveUS20080255637A1Curb consumptionAvoid side effectsCavity massageBathing devicesTreatment effectMedicine
A method for treating a disease by returning the body to a natural condition. The method adjusts a parameter of a thermotherapy for treating or preventing the disease, disability, or condition of a patient and comprises (A) a step of measuring the redox potential (or pH value) of the patient and (B) a step of determining the parameter of thermotherapy suited to the patient according to the redox potential. Considering returning the biopotential to a range called homeostatic potential, a therapeutic potential of −75 mV to −90 mV (the potential in the cell is −75 mV) the absolute value of which is higher than that of the cell is given. It has been found that this therapy effects a cure.
Owner:CHICKEN CORP
Composition comprising theanine
Owner:TAIYO KAGAKU CO LTD
Composition comprising theanine
InactiveUS20010001307A1Low costSuppress symptomsBiocideHeavy metal active ingredientsMedicineTheanine
The present invention relates to a composition for suppressing or ameliorating a symptom accompanying diminished homeostasis, comprising theanine; and a mineral composition comprising theanine and a mineral. According to the present invention, there can be provided a composition for suppressing or ameliorating the above symptoms; and a mineral composition having a reduced peculiar metal taste, of which administration is made easily.
Owner:TAIYO KAGAKU CO LTD
Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
Owner:NGM BIOPHARMLS
Embryoid Body - Based Screen
InactiveUS20070015210A1Uniform sizeEasy to produceGenetically modified cellsLibrary screeningTest agentConceptus
Disclosed are embryoid bodies having a uniform size of approximately 415 nm and comprising genetically modified embryonic stem cells, and methods of making same. The genetically uniform embryoid bodies can be multiplexed as one embryoid body per well in a multiwell format, and used as a high to medium throughput screen for test agents that affect the development and homeostasis of animals, including humans. The genetic modification of the embryonic stem cells is a promoter-report-selection construct that enables the selection and detection of cells of a particular lineage in the EB, to determine the effects of a test agent.
Owner:GENEPROTECH
Methods for affecting homeostasis and metabolism in a mammalian body
InactiveUS20050233014A1Effective quantityLow production costOrganic active ingredientsBiocideCysteine thiolateTryptophan
The present invention is directed to novel compositions of bio-active compounds comprising 4-hydroxyisoleucine and one or more compounds selected from the group of amino acids, alkaloids, glycosides, volatile oils, saponins, sapogenins, mannans, flavonoids, fatty acids, vitamins and provitamins, minerals, and carbohydrates. Preferably, the novel compositions of bio-active compounds include 4-hydroxyisoleucine and one or more amino acids selected from the group consisting of arginine, aspartate, threonine, serine, glutamate, proline, glycine, alanine, cysteine, valine, methionine, isoleucine, leucine, tryptophan, phenylalanine, ornithine, proline, lysine, histidine, and gamma-aminobutyrate. The composition of bio-active compounds preferably include between about ten percent and about seventy percent of 4-hydroxyisoleucine and between about twenty percent and about forty percent of other amino acids. The bio-active compounds of the novel composition of the present invention may be derived, isolated, and / or extracted from Fenugreek seeds. A preferred method for extracting the bio-active compounds from Fenugreek seeds includes the steps of: (1) providing a plurality of Fenugreek seeds; (2) preparing the Fenugreek seeds; and (3) extracting a novel composition of bio-active compounds from the Fenugreek seeds, which include a preliminary extraction step and a secondary extraction step. The compositions of bio-active compounds have been found to be helpful in restoring healthy energy balance in humans and animals, aiding in weight management efforts, and for balancing blood sugar levels by way of assisting the body to make more efficient use of existing (i.e., endogenous) insulin.
Owner:TSI INC
Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress
A pharmaceutical delivery system comprising a slow-release formulation of vitamin C (ascorbic acid) and a plain-release formulation of vitamin E (tocopherol) has been found to raise and maintain the concentrations of these vitamins in the blood plasma to a ratio of approximately 2.2:1. The steady-state concentration and ratio of these antioxidants has been found to be critical in the prevention and treatment of oxidative stress related disorders such as arteriosclerosis and diabetes and neural degenerative disorders such as Alzheimer's Disease.
Owner:AS FERROSAN
Homeostatic flying hovercraft
InactiveUS20080223993A1Easy to controlEasy to useAircraft navigation controlFlying saucersFly-by-wireEngineering
A homeostatic flying hovercraft preferably utilizes at least two pairs of counter-rotating ducted fans to generate lift like a hovercraft and utilizes a homeostatic hover control system to create a flying craft that is easily controlled. The homeostatic hover control system provides true homeostasis of the craft with a true fly-by-wire flight control and control-by-wire system control.
Owner:QFO LABS
Cosmetic and cosmeceutical compositions for restoration of skin barrier function
InactiveUS20060182770A1Restoring skin barrier functionMaintain steady stateBiocideOrganic active ingredientsSkin barrier functionPotassium ions
Compositions, kits and methods are provided for restoring skin barrier function to skin exposed to environmental elements and / or in a pathological condition. In general, divalent cations such as calcium ions and / or magnesium ions are included in a physiologically acceptable medium. In some embodiments, divalent cations are balanced with monovalent cations such as sodium and potassium ions at appropriate ratios in order to maintain the homeostasis of skin barrier. The compositions, kits and methods can be used as cosmetics, cosmeceuticals or pharmaceuticals for improving skin condition, and preventing or treating dermatological diseases and skin disorders.
Owner:GENEPHARM
Method and composition of novel compounds for the therapy and targeting of the primary modalities of cancer cell proliferation and homeostasis
The invention is of both a composition and method for inhibiting the proliferation of cancerous cells. The composition is, and the method is based on the use of a composition consisting (among active ingredients) substantially of 2-methoxyestradiol and / or one of a number of anaologues thereof. The present inventors have demonstrated beyond serious doubt that these compounds have a pronounced effect in inhibiting the proliferation of cancerous cells and, therefore, provide a desperately needed stepping stone for advancing toward meaningful treatment of cancer.
Owner:ONCOLOGY SCI CORP
Biocidic packaging for cosmetics and foodstuffs
InactiveUS20100178268A1Effective functionElectrical balance is disruptedBiocideFood preservationElectricityCell–cell interaction
The present invention presents a biocidic packaging for cosmetics and / or foodstuffs, comprises at least one insoluble proton sink or source (PSS). The packaging is provided useful for killing living target cells (LTCs), or otherwise disrupting vital intracellular processes and / or intercellular interactions of said LTC upon contact. The PSS comprises, inter alia, (i) proton source or sink providing a buffering capacity; and (ii) means providing proton conductivity and / or electrical potential. The PSS is effectively disrupting the pH homeostasis and / or electrical balance within the confined volume of the LTC and / or disrupting vital intercellular interactions of the LTCs while efficiently preserving the pH of said LTCs' environment. The present invention also discloses a method for killing living target cells (LTCs), or otherwise disrupting vital intracellular processes and / or intercellular interactions of said LTC being in a packaging, especially cosmetic or foodstuffs' packaging.
Owner:OPLON
Method and composition of novel compounds for the therapy and targeting of the primary modalitites of cancer cell proliferation and homeostasis
Owner:ONCOLOGY SCI CORP
Calcium receptor antagonist
InactiveUS6916956B2Superior calcium receptor antagonistic actionBiocideOrganic compound preparationNK1 receptor antagonistAbnormal calcium
Owner:JAPAN TOBACCO INC
Use of WNT inhibitors to augment therapeutic index of chemotherapy
InactiveUS7803783B2Increase doseOrganic active ingredientsPeptide/protein ingredientsIntestinal structureWnt inhibitor
Methods and compositions are provided for the protection of normal cells from cytoreductive therapy that target proliferating cells, by administering an inhibitor of Wnt signaling pathways. Wnt signaling is critically important for homeostasis of the epithelial lining of the adult intestine and other proliferating normal adult tissues.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Osteogenetic-orthodontic device, system, and method
ActiveUS7887324B2Induce craniofacial homeostasisIncrease and enhanceOthrodonticsDental toolsFacial regionCraniofacial
Owner:VIVOS THERAPEUTICS INC
Modulation of physiological processes and agents useful for same
The present invention relates generally to a method of modulating glutathione metabolism in the central nervous system of mammals and to agents for use therein. More particularly, the present invention relates to a method of up-regulating glutathione metabolism in the central nervous system by up-regulating levels of glutathione precursor molecules. The method of the present invention is particularly useful, inter alia, in the treatment and / or prophylaxis of conditions characterised by aberrant, unwanted or otherwise inappropriate central nervous system oxidation homeostasis including, but not limited to, schizophrenia.
Owner:THE MENTAL HEALTH RES INST OF VICTORIA
Method of preparing antimicrobial hemostasis Chinese medicine-containing biological dressings
InactiveCN101138648AGood biocompatibilitySignificant securityAbsorbent padsBandagesWoven fabricHomeostatic mechanism
The present invention is a biological dressing produced by the extraction liquid of the Chinese medicine with antibacterial and homeostasis properties comprising the soaking gall and the notoginseng, which takes the cotton, gauze or non-woven fabrics as the substrate and the chitosan as the membrane forming material. The present invention can be applied in the wound dressing for the burning wound and the injury. The present invention has characteristics of good biocompatibility, safety property, absorbing the wound exudates, antibacterial property, and homeostasis property and accelerating the healing in the wound. The main material of the present invention is the natural material.
Owner:UNIV OF ELECTRONICS SCI & TECH OF CHINA ZHONGSHAN INST
Method for Evaluating Physical Conditions Using Head Hair or Body Hair
InactiveUS20070258561A1Easy to handleEasy to implementMaterial analysis using wave/particle radiationX-ray spectral distribution measurementScreening cancerHair roots
It is intended to provide a method of improving dietary life or screening cancer which comprises measuring the content of an element in head hair or body hair, paying attention to the fact that the content of the element remains constant in healthy humans (i.e., homeostasis) and thus evaluating the physical conditions based on changes in the homeostasis. Namely, a method of evaluating the physical conditions whereby the physical conditions can be evaluated by measuring the content of an element in an arbitrary part of head hair or body hair. Although one's physical conditions change everyday, these changes are scarcely self-noticeable. Therefore, it is required to objectively indicate such changes in the physical conditions in numerical terms. Because of being solid, head hair or body hair can be easily handled. Thus, they are most suitable for analyzing the content of an element and enable large-scaled diagnosis at fixed intervals. This method of evaluating the physical conditions using head hair or body hair, whereby the content of an element at present can be measured by analyzing the hair root while its content of the past can be measured by analyzing at an arbitrary part, is highly effective in evaluating the physical conditions.
Owner:CHIKAWA JUN ICHI
System and methods for stress release and associated nitric oxide release for treatment of pain in specific parts of the body
InactiveUS20090124865A1Avoid painRelief the painChiropractic devicesMassageStress inducedPulmonary vasculature
This invention provides unique technology, systems and methods of treatment of stress induced afflictions in the musculoskeletal system, the vascular system or the nervous tissue. More specifically, the systems comprise diagnosis of a stress-induced consistent tightness on the right side of the cranial, cervical, thoracic, lumbar, sacral spine, referred herein as “The Twist”, and utilize “Stress Relief Methods” to reduce The Twist to resolve any afflictions associated with it. The invention comprises a coordinated series of untwisting dynamic motions, spinal manipulation and / or motion palpations that result in release of nitric oxide and relief from pain. The systems and methods of the invention therefore provide the benefits of increased nitric oxide release to maintain homeostasis in pulmonary vasculature. The invention also provides methods of training others in the correct use of the Stress Relief Methods to prevent and treat afflictions associated with the Twist.
Owner:KIERNAN JAMES E
Compositions and method for steroid homeostasis
InactiveUS20050032743A1Good for bone healthBiocideVitamin food ingredientsBone densityDietary supplement
Methods and compositions are directed to a dietary supplement comprising boron that is an a complex with a carbohydrate, wherein administration of the complex increases steroid levels, and particularly 25-hydroxy vitamin D3. Thus, contemplated compositions are useful for treatment of impaired steroid homeostasis, and especially beneficial for prevention and / or treatment of bone density loss. Particularly preferred compositions further include calcium, magnesium, and / or vitamin D in a nutritionally acceptable form.
Owner:VDF FUTURECEUTICALS
Preparations to support maintenance of acid-alkaline balance in the human body and methods directed to using same
InactiveUS20070003613A1Reduce ambient pHImprove efficiencyBiocideDispersion deliveryHuman bodyGlycerol
The present invention provides novel compositions in the form of a powder, capsule, liquid or lozenge, and methods for administering said novel compositions to assist the body in its ability to maintain a reasonable homeostatic mechanism for compensating for chronic internal acidity. The composition may contain several active ingredients, such as potassium bicarbonate, citric acid, calcium citrate, magnesium citrate, glycine, and licorice. The composition may also contain other inactive excipients, such as hypoallergenic rice, flour, glycerine, tangerine oil and gelatin. Following oral administration, the composition is rapidly broken down and absorbed into the systemic circulation. Upon absorption, the individual components are able to assist the physiological acid-alkaline buffer systems, promote anti-anxiety effects, and decrease inflammation in the digestive system.
Owner:TRIMEDICA INT
Device for determining biological state during driving and computer program
ActiveUS20150327803A1Accurately determineDiagnostic recording/measuringSensorsDriver/operatorDynamic equilibrium
A device determining a biological state of a driver more accurately, including a hypnagogic symptom phenomenon detecting mechanism, an imminent sleep phenomenon detecting mechanism, a subjective sleepiness / low consciousness traveling state detecting mechanism, and a homeostasis function level determining mechanism, which are configured to function in parallel. Therefore, detection of a hypnagogic symptom phenomenon or an imminent sleep phenomenon, or detection of a period resisting a light sleepiness mild sleepiness or a strong sleepiness which occurs consciously, or the case where a low consciousness traveling state due to a decrease in consciousness level momentarily occurs or the case where it occurs longer continuously, or the like, can be determined / detected, and the driver's biological state can be accurately determined
Owner:DELTA TOOLING CO LTD
Osteogenetic-orthodontic device, system, and method
ActiveUS20090087810A1Easy to keepInduce craniofacial homeostasisOthrodonticsDental toolsFacial regionCraniofacial
In a preferred embodiment of the present invention, an osteogenetic-orthodontic appliance, device, system, and method optimizes craniofacial homeostasis by means of a 3-D axial spring that influences the patient's genome and thereby addresses problems existing primarily within the mid-facial region, as well as the other contiguous regions. Growth and development of the craniofacial structures can be influenced by foundational (skeleto-dental) correction in concert with functional (myo-spatial) correction, according to the genome of a particular patient by means of the method and systems of the present invention.
Owner:VIVOS THERAPEUTICS INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com